References
- Stafford, RS; Ma, J; Finkelstein, SN; Haver, K; and Cockburn I. National trends in asthma visits and asthma pharmacotherapy, 1978–2002. J Allergy Clin Immunol 2003, 111(4): 730–5.
- Lee, Lee and Kavanaugh, AF. Autoimmunity, vasculitis, and autoantibodies. J Allergy Clin Immunol 2005, 117(2): S445–50.
- Park, H; Li, Z; Yang, XO; Chang, SH; Nurieva, R; Wang, Y-H; Wang, Y; Hood, R; Zhu, Z; Tian, Q; Dong, C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nature Immunology, October 2005. Available at http://www.nature.com/natureimmunology (Accessed 22/02/2006).
- Howarth, PH; Babu, KS; Arshad, HS; Lau, L; Buckley, M; McConnell, W; Beckett, P Al; Ali, M; Chauhan, A; Wilson, SJ; Reynolds, A; Davies, DE and Holgate, ST. 2005. Tumour Necrosis Factor (TNF_) as a Novel Therapeutic Target in Symptomatic Corticosteroid-Dependent Asthma. Thorax Online First, published on September 15, 2005 as 10.1136/thx.2005.045260 (Accessed 22/02/2006).
- Sibilia, Sibilia and Griscelli, Griscelli. Immunotherapy of inflammatory diseases, 2005. Expert Opin. Biol. Ther. 2005, 5(suppl. 1): S1–S13
- Van de Putte L, and Nichol, MB. Adalimumab for rheumatoid arthritis: Considerations for reimbursement by third-party payors. Dis Manag Health Outcomes 2004, 12(1): 1–8.
- Breedveld, FC; Weisman, MH; Kavanaugh, AF; Cohen, SB; Pavelka, K van; Vollenhoven, R; Sharp, J; Perez, JL and Spencer-Green, GT. The Premier Study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis & Rheumatism 2006, 54(1): 26–37.
- Russo, Russo and Polosa, Polosa. TNF-alpha as a promising therapeutic target in chronic asthma: a lesson from rheumatoid arthritis. Clinical Science 2005, 109(2): 135–42.
- Erzurum, Erzurum. Inhibition of tumor necrosis factor (alpha) for refractory asthma. New England Journal of Medicine 2006, 354(7): 754–758.
- Keystone, EC. Safety of biologic therapies—an update. The Journal of Rheumatology 2005, 32(suppl. 74): 8–12.